256 related articles for article (PubMed ID: 20309627)
21. Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study.
Poynter JN; Langholz B; Largent J; Mellemkjaer L; Bernstein L; Malone KE; Lynch CF; Borg A; Concannon P; Teraoka SN; Xue S; Diep AT; Törngren T; Begg CB; Capanu M; Haile RW; ; Bernstein JL
Cancer Causes Control; 2010 Jun; 21(6):839-46. PubMed ID: 20130978
[TBL] [Abstract][Full Text] [Related]
22. Clinical and pathological features of BRCA1/2 tumors in a sample of high-risk Moroccan breast cancer patients.
Jouhadi H; Tazzite A; Azeddoug H; Naim A; Nadifi S; Benider A
BMC Res Notes; 2016 Apr; 9():248. PubMed ID: 27129401
[TBL] [Abstract][Full Text] [Related]
23. Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Kotsopoulos J; Lubinski J; Salmena L; Lynch HT; Kim-Sing C; Foulkes WD; Ghadirian P; Neuhausen SL; Demsky R; Tung N; Ainsworth P; Senter L; Eisen A; Eng C; Singer C; Ginsburg O; Blum J; Huzarski T; Poll A; Sun P; Narod SA;
Breast Cancer Res; 2012 Mar; 14(2):R42. PubMed ID: 22405187
[TBL] [Abstract][Full Text] [Related]
24. Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.
Friebel TM; Domchek SM; Rebbeck TR
J Natl Cancer Inst; 2014 Jun; 106(6):dju091. PubMed ID: 24824314
[TBL] [Abstract][Full Text] [Related]
25. Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers.
Milne RL; Antoniou AC
Endocr Relat Cancer; 2016 Oct; 23(10):T69-84. PubMed ID: 27528622
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry.
Fernandes GC; Michelli RA; Galvão HC; Paula AE; Pereira R; Andrade CE; Felicio PS; Souza CP; Mendes DR; Volc S; Berardinelli GN; Grasel RS; Sabato CS; Viana DV; Mauad EC; Scapulatempo-Neto C; Arun B; Reis RM; Palmero EI
Oncotarget; 2016 Dec; 7(49):80465-80481. PubMed ID: 27741520
[TBL] [Abstract][Full Text] [Related]
27. Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study.
Giannakeas V; Lubinski J; Gronwald J; Moller P; Armel S; Lynch HT; Foulkes WD; Kim-Sing C; Singer C; Neuhausen SL; Friedman E; Tung N; Senter L; Sun P; Narod SA
Breast Cancer Res Treat; 2014 Aug; 147(1):113-8. PubMed ID: 25082516
[TBL] [Abstract][Full Text] [Related]
28. Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin.
Wolf I; Laitman Y; Rubinek T; Abramovitz L; Novikov I; Beeri R; Kuro-O M; Koeffler HP; Catane R; Freedman LS; Levy-Lahad E; Karlan BY; Friedman E; Kaufman B
Oncogene; 2010 Jan; 29(1):26-33. PubMed ID: 19802015
[TBL] [Abstract][Full Text] [Related]
29. Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations.
Yao L; Sun J; Zhang J; He Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
Breast Cancer Res Treat; 2016 Apr; 156(3):441-445. PubMed ID: 27033093
[TBL] [Abstract][Full Text] [Related]
30. Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Graeser MK; Engel C; Rhiem K; Gadzicki D; Bick U; Kast K; Froster UG; Schlehe B; Bechtold A; Arnold N; Preisler-Adams S; Nestle-Kraemling C; Zaino M; Loeffler M; Kiechle M; Meindl A; Varga D; Schmutzler RK
J Clin Oncol; 2009 Dec; 27(35):5887-92. PubMed ID: 19858402
[TBL] [Abstract][Full Text] [Related]
31. The sex hormone system in carriers of BRCA1/2 mutations: a case-control study.
Widschwendter M; Rosenthal AN; Philpott S; Rizzuto I; Fraser L; Hayward J; Intermaggio MP; Edlund CK; Ramus SJ; Gayther SA; Dubeau L; Fourkala EO; Zaikin A; Menon U; Jacobs IJ
Lancet Oncol; 2013 Nov; 14(12):1226-32. PubMed ID: 24140203
[TBL] [Abstract][Full Text] [Related]
32. Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers.
Milne RL; Osorio A; Ramón y Cajal T; Baiget M; Lasa A; Diaz-Rubio E; de la Hoya M; Caldés T; Teulé A; Lázaro C; Blanco I; Balmaña J; Sánchez-Ollé G; Vega A; Blanco A; Chirivella I; Esteban Cardeñosa E; Durán M; Velasco E; Martínez de Dueñas E; Tejada MI; Miramar MD; Calvo MT; Guillén-Ponce C; Salazar R; San Román C; Urioste M; Benítez J
Breast Cancer Res Treat; 2010 Jan; 119(1):221-32. PubMed ID: 19370414
[TBL] [Abstract][Full Text] [Related]
33. Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers in a large cohort of unselected Chinese breast cancer patients.
Su L; Xu Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
Int J Cancer; 2020 Jun; 146(12):3335-3342. PubMed ID: 32037537
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic features and genetic characteristics of the BRCA1/2 mutation in Turkish breast cancer patients.
Cecener G; Sabour Takanlou L; Sabour Takanlou M; Egeli U; Eskiler GG; Aksoy S; Unal U; Tezcan H; Eryilmaz IE; Gokgoz MS; Tunca B; Cubukcu E; Evrensel T; Cetintas S; Tasdelen I
Cancer Genet; 2020 Jan; 240():23-32. PubMed ID: 31706072
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations.
de Bruin MA; Kwong A; Goldstein BA; Lipson JA; Ikeda DM; McPherson L; Sharma B; Kardashian A; Schackmann E; Kingham KE; Mills MA; West DW; Ford JM; Kurian AW
Fam Cancer; 2012 Sep; 11(3):429-39. PubMed ID: 22638769
[TBL] [Abstract][Full Text] [Related]
36. Breast cancer risk for Korean women with germline mutations in BRCA1 and BRCA2.
Park B; Dowty JG; Ahn C; Win AK; Kim SW; Lee MH; Lee JW; Kang E; Hopper JL; Park SK
Breast Cancer Res Treat; 2015 Aug; 152(3):659-65. PubMed ID: 26195121
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group.
Anglian Breast Cancer Study Group
Br J Cancer; 2000 Nov; 83(10):1301-8. PubMed ID: 11044354
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer risk in BRCA1/2 mutation carriers and noncarriers under prospective intensified surveillance.
Engel C; Fischer C; Zachariae S; Bucksch K; Rhiem K; Giesecke J; Herold N; Wappenschmidt B; Hübbel V; Maringa M; Reichstein-Gnielinski S; Hahnen E; Bartram CR; Dikow N; Schott S; Speiser D; Horn D; Fallenberg EM; Kiechle M; Quante AS; Vesper AS; Fehm T; Mundhenke C; Arnold N; Leinert E; Just W; Siebers-Renelt U; Weigel S; Gehrig A; Wöckel A; Schlegelberger B; Pertschy S; Kast K; Wimberger P; Briest S; Loeffler M; Bick U; Schmutzler RK;
Int J Cancer; 2020 Feb; 146(4):999-1009. PubMed ID: 31081934
[TBL] [Abstract][Full Text] [Related]
39. Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis.
Basu NN; Ingham S; Hodson J; Lalloo F; Bulman M; Howell A; Evans DG
Fam Cancer; 2015 Dec; 14(4):531-8. PubMed ID: 26239694
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.
Eisen A; Lubinski J; Klijn J; Moller P; Lynch HT; Offit K; Weber B; Rebbeck T; Neuhausen SL; Ghadirian P; Foulkes WD; Gershoni-Baruch R; Friedman E; Rennert G; Wagner T; Isaacs C; Kim-Sing C; Ainsworth P; Sun P; Narod SA
J Clin Oncol; 2005 Oct; 23(30):7491-6. PubMed ID: 16234515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
